News
First, thanks to those who helped with the poster session and those who showed up to support the trainees! The event was a big success, and everyone seemed to have a good time! Here are the winners:
Postdoc Category – Invited to speak at the Dean’s Distinguished Lecture Series in early May
1st place – Dr. Lindsey R. Conroy – Markey Cancer Center – “Visualization of lung tumor microenvironmental glycogen by next generation digital pathology” – winner of $700
LEXINGTON, Ky. (April 1, 2021) – The STEM Through Authentic Research and Training (START) program at the University of Kentucky is creating a unique pipeline to increase science, technology, engineering and math (STEM) literacy and promote STEM careers for traditionally underrepresented populations (people of color, individuals with disabilities, students from free or reduced lunch schools), first-generation college students, and girls and women in STEM.
LEXINGTON, Ky. (Jan. 22, 2021) — While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight against the global pandemic.
The emergency authorization allows us to protect people now, but research will continue for decades, says University of Kentucky College of Medicine vaccine researcher Jerry Woodward.
Lyme disease is the most common vector-borne bacterial disease in the U.S., with 200,000 new cases each year. While incidence in Kentucky typically has been relatively low, the incidence of the tick vector, lxodes scapularis, has increased over the past five years, even spreading to areas it did not previously live.
LEXINGTON, Ky. (Sept. 17, 2020) — A new University of Kentucky College of Medicine study may provide answers for why so many COVID-19 patients experience thrombosis, or the formation of blood clots that obstruct blood flow through the circulatory system.
LEXINGTON, Ky. (Aug. 18, 2020) — The University of Kentucky Society of Postdoctoral Scholars (SOPS) hosted their first Research Pitch Competition where 19 postdocs and fellows showcased their research with one-minute elevator pitches.
LEXINGTON, Ky. (Aug. 13, 2020) — PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
Throughout the summer the University of Kentucky College of Medicine has been part of a University-wide pilot program aiming to help boost resumes and build important skills for both UK and non-UK students.
The Summer Badge Program is not your average summer school. The program provides an opportunity for learners to complete courses and earn digital badges, regardless of their current major, with the badges certifying competency in a specific skill.
LEXINGTON, Ky. (May 11, 2020) — University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. Several research labs and core facilities within UK’s Colleges of Medicine and Pharmacy will be testing the antibodies of recovered COVID-19 patients for a study to see how long they protect against reinfection.
Subbarao Bondada, professor of microbiology in the Department of Microbiology, Immunology and Molecular Genetics in the University of Kentucky College of Medicine and Markey Cancer Center, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.
Our own Dr. Subba Bondada has been elected to the rank of AAAS Fellow in the Section on Medical Sciences by the Council of the American Association for the Advancement of Science.
From Dr. Bondada's award letter: Each year the Council elects members whose “efforts on behalf of the advancement of science or its applications are scientifically or socially distinguished.” On behalf of the Council of the American Association for the Advancement of Science, I am very pleased to inform you of your election to the rank of AAAS Fellow.
Congratulations Dr. Bondada!
Members of Microbiology, Immunology, and Molecular Genetics and staff in the Office of Biomedical Education enjoyed the opportunity to show off their Halloween outfits!
Eleven presenters participated in the 3 Minute Thesis Competition at the Fifth Annual Infectious Diseases Research Day held on October 17, 2019.
From left to right:
3rd place is Taylor Lundy, Graduate Student in Dr. Sylvie Garneau-Tsodikova's lab in the Department of Pharmaceutical Sciences
2nd place is Gabrielle Keb, Graduate Student in Dr. Ken Fields' lab in the Department of Microbiology, Immunology, and Molecular Genetics
A unique partnership between an engineer and a scientist at the University of Kentucky has produced data that is challenging prevailing wisdom about a potentially life-threatening parasite's behavior and revealing possible targets for treatment.
Decades of research and treatment advances have helped extend the lives of many people living with HIV, but while these patients live longer, their risk of developing dangerous blood clots increases as much as tenfold. Blood clots – also known as thrombi – can wreak havoc on the body, causing events such as debilitating strokes and heart attacks.
